Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- WuXi Will End Biologics Manufacturing In US
Dec 02, 2008 01:59 PM
- WuXi PharmaTech Inks New Three-year Deal with Pfizer
Nov 07, 2008 01:56 PM
- WuXi Misses Q3 Forecast; Guides Lower for Year
Oct 14, 2008 05:10 PM
- The Week In Review: Economic Troubles
Oct 11, 2008 09:08 PM
- WuXi PharmaTech And Covance Nix Partnership
Sep 29, 2008 01:00 PM
- WuXi Reports Solid Q2 Financials
Aug 14, 2008 02:53 PM
- WuXi PharmaTech Earnings
Aug 14, 2008 01:43 PM
- Chinese Healthcare Sector ADRs
Aug 07, 2008 02:00 PM
- WuXi: Secret Weapon in Drug Research
Jul 30, 2008 10:08 AM
- CRO Consolidation: Indian Firm Veeda Buys US CRO
Jul 17, 2008 01:11 PM
- WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
Dec 02, 2008 05:00 AM
- WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
Nov 27, 2008 05:47 AM
- Wrangler West Reports Strong Revenue in 2008 Nine Months
Nov 17, 2008 03:32 PM
- WuXi PharmaTech Announces Third Quarter 2008 Results
Nov 12, 2008 07:00 PM
- WuXi PharmaTech Appoints Ying Han to Its Board of Directors
Nov 12, 2008 07:00 PM
- WuXi PharmaTech Awarded in Deloitte Technology Fast 50 China 2008 List for the Fourth Consecutive Year
Nov 10, 2008 06:08 AM
- WuXi PharmaTech Signs New Collaboration Agreement With Pfizer
Nov 07, 2008 02:12 AM
- WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
Oct 23, 2008 06:06 AM
- WuXi PharmaTech Expands Collaboration for Fully Integrated Services
Oct 16, 2008 03:35 AM
- WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
Oct 14, 2008 04:31 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
WX
|
Compare to S&P
|
| YTD |
-79.55 %
|
-66.49 %
|
| 4 Weeks |
-36.11 %
|
-30.94 %
|
| 12 Weeks |
-65.83 %
|
-52.63 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 5.88 %
|
|
EPS Growth in Last Year: 50.00 %
|
|
Sales Growth in Last Quarter: -4.75 %
|
|
Sales Growth in Last Quarter: 98.16 %
|
|
|
